[go: up one dir, main page]

NO20061458L - Infusjonspreparat inneholdende (2R)-2-propyloktansyre som den aktive bestanddel - Google Patents

Infusjonspreparat inneholdende (2R)-2-propyloktansyre som den aktive bestanddel

Info

Publication number
NO20061458L
NO20061458L NO20061458A NO20061458A NO20061458L NO 20061458 L NO20061458 L NO 20061458L NO 20061458 A NO20061458 A NO 20061458A NO 20061458 A NO20061458 A NO 20061458A NO 20061458 L NO20061458 L NO 20061458L
Authority
NO
Norway
Prior art keywords
infusion preparation
propyloctanoic acid
preparation containing
active ingredient
salt
Prior art date
Application number
NO20061458A
Other languages
English (en)
Inventor
Masao Sudoh
Seiichi Tanikawa
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of NO20061458L publication Critical patent/NO20061458L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Et infusjonspreparat som inneholder (2R)-2-propyloktansyre eller dens salt som er anvendbart i behandling av neurodegenerative sykdommer og et basisk metallion avlevert fra et metallsalt av en svak syre eller et metallhydroksyd foretrukket i en mengde på omtrent 1 til omtrent 5 ekvivalenter per ekvivalent av (2R)-2-propyloktansyren eller dens salt eventuelt sammen med en eller flere andre infusjonskomponenter. Dette infusjonspreparatet har en pH-verdi som er passende for intravenøs administrering og er anvendbart i kontinuerlig intravenøs administrering uten et behov for noen forbehandling slik som oppløsning eller fortynning før anvendelse.
NO20061458A 2003-10-03 2006-03-31 Infusjonspreparat inneholdende (2R)-2-propyloktansyre som den aktive bestanddel NO20061458L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003345125 2003-10-03
PCT/JP2004/014896 WO2005032538A1 (ja) 2003-10-03 2004-10-01 (２ｒ)−２−プロピルオクタン酸を有効成分とする輸液製剤

Publications (1)

Publication Number Publication Date
NO20061458L true NO20061458L (no) 2006-07-03

Family

ID=34419442

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061458A NO20061458L (no) 2003-10-03 2006-03-31 Infusjonspreparat inneholdende (2R)-2-propyloktansyre som den aktive bestanddel

Country Status (17)

Country Link
US (1) US20070066686A1 (no)
EP (1) EP1669066A4 (no)
JP (1) JP4715516B2 (no)
CN (1) CN1889941A (no)
AU (1) AU2004277828A1 (no)
BR (1) BRPI0414968A (no)
CA (1) CA2540671A1 (no)
EC (1) ECSP066476A (no)
IL (1) IL174691A0 (no)
IS (1) IS8428A (no)
MA (1) MA28143A1 (no)
MX (1) MXPA06003605A (no)
NO (1) NO20061458L (no)
RU (1) RU2006114834A (no)
SG (1) SG146690A1 (no)
WO (1) WO2005032538A1 (no)
ZA (1) ZA200602689B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7980168B2 (en) * 2007-06-26 2011-07-19 Maurer Scott D Hot beverage maker with filter deforming member
US20100130619A1 (en) * 2008-11-24 2010-05-27 Joseph Schwarz Pharmaceutical composition for parenteral administration of idebenone
CN104931424A (zh) * 2015-05-06 2015-09-23 山东师范大学 一种改进的z扫描非线性测量的实验装置及方法
CN109593676B (zh) * 2018-12-21 2023-04-07 江苏大学 一种用于酸菜发酵液中微生物分离的培养基及其制备方法
CA3129732A1 (en) * 2019-02-14 2020-08-20 North Grove Investments, Inc. Compositions for maintaining the viability of living and static biological material, methods of making and the uses thereof
RU2699222C1 (ru) * 2019-04-29 2019-09-04 Алексей Владимирович Воронов Солевой электролитный раствор для проведения энтеральных инфузий

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0632008T3 (da) * 1993-06-01 1998-09-23 Ono Pharmaceutical Co Pentansyrederivater
JPH0782146A (ja) * 1993-07-23 1995-03-28 Sagami Chem Res Center 抗痴呆薬
JPH07285911A (ja) * 1994-04-20 1995-10-31 New Japan Chem Co Ltd 脂肪族モノカルボン酸組成物
JPH0853351A (ja) * 1994-08-11 1996-02-27 Sagami Chem Res Center 酵素阻害剤、血管新生抑制剤、および癌転移抑制剤
US6043223A (en) * 1997-11-12 2000-03-28 The Regents Of The University Of California Enhanced opening of abnormal brain tissue capillaries
TWI268921B (en) * 1999-02-18 2006-12-21 Ono Pharmaceutical Co A process for preparing (2R)-2-propyloctanoic acid
KR20030009454A (ko) * 2000-05-31 2003-01-29 카가쿠키쥬쯔 신코지교단 진세노사이드Ｒｂ1으로 된 피부조직 재생촉진제
JP4706950B2 (ja) * 2000-07-18 2011-06-22 小野薬品工業株式会社 アストロサイト機能改善剤を有効成分として含有するパーキンソン病治療剤
KR100759771B1 (ko) * 2000-07-18 2007-10-04 오노 야꾸힝 고교 가부시키가이샤 성상세포 기능 개선제를 유효 성분으로 함유하는 파킨슨병치료제
KR20080100290A (ko) * 2001-07-18 2008-11-14 오노 야꾸힝 고교 가부시키가이샤 뇌허혈 질환 치료제

Also Published As

Publication number Publication date
IS8428A (is) 2006-04-25
WO2005032538A1 (ja) 2005-04-14
IL174691A0 (en) 2006-08-20
AU2004277828A1 (en) 2005-04-14
ECSP066476A (es) 2007-03-29
RU2006114834A (ru) 2007-11-20
MXPA06003605A (es) 2006-06-14
ZA200602689B (en) 2007-06-27
SG146690A1 (en) 2008-10-30
US20070066686A1 (en) 2007-03-22
MA28143A1 (fr) 2006-09-01
CA2540671A1 (en) 2005-04-14
EP1669066A1 (en) 2006-06-14
BRPI0414968A (pt) 2006-11-07
JP4715516B2 (ja) 2011-07-06
CN1889941A (zh) 2007-01-03
JPWO2005032538A1 (ja) 2006-12-14
EP1669066A4 (en) 2009-04-29

Similar Documents

Publication Publication Date Title
TW200838545A (en) Therapeutic agent for painful disease
EA201200490A1 (ru) Стабильный совместный состав, содержащий хиалуронидазу и иммуноглобулин, и способы его применения
RU2002106399A (ru) Составы моксифлоксацина, содержащие поваренную соль
NO20061460L (no) Legemiddel inneholdende (2R)-2-propyloktansyre som den aktive bestanddel
KR20130080422A (ko) 엔로플록사신의 주사제 및 그의 제조방법
NO20061458L (no) Infusjonspreparat inneholdende (2R)-2-propyloktansyre som den aktive bestanddel
DK1673074T3 (da) Flydende præparat, indeholdende tobramycin
WO2012044783A8 (en) Method of achieving a thymosin beta 4 concentration in a human patient
EP2614821A1 (en) Pharmaceutical composition for treating anxiety disorder, containing n-acetyl-l-cysteine or derivative thereof
WO2014015444A1 (de) Verwendung zur intravenösen injektion von isotonisch-physiologischem elektrolysewasser zur bekämpfung von systematischen virosen und bakteriosen mittels oxidativen radikalen
HRP20200031T1 (hr) Uporaba cerebrolizina
EP3071189A1 (en) Injectable pharmaceutical compositions comprising iloprost
CN110101657A (zh) 一种左氧氟沙星单剂量滴眼液及其制备方法
DE04291738T1 (de) Verwendung von Citrullin zur Herstellung eines Arzneimittels zur Behandlung von intestinaler Insuffizienz
EP3366288B1 (en) Lithium ascorbate exhibiting anti-stress, anxiolytic and anti-depression activity
AU2004263036B2 (en) Glycyrrhizin high-concentration preparation
EP2747756A1 (de) Metabolisierbare salze und deren verwendung in diagnostik und therapie
CN102258463A (zh) 一种稳定的亚叶酸钠注射液
Stokinger Absorption, Acetylation, and Excretion of 2 Sulfanilamido Pyridine (Dagenan, M & B 693).
JP2016190833A (ja) 水素分子による乾癬患者における皮膚関節症状およびサイトカイン改善作用
West et al. Absence of respiratory change or manifest tetany with elevation of plasma pH produced by bicarbonate administration in dogs
RU2533257C1 (ru) Инфузионный раствор "физиолит"
RU2229884C2 (ru) Способ стабилизации раствора ципрофлоксацина для инфузий
RU2713167C1 (ru) Способ лечения гепатитов и состав для его осуществления
RU2747928C2 (ru) Состав для приготовления лечебно-профилактических ванн

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application